These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Melanin pigmentation of the skin in primary biliary cirrhosis. Mills PR; Skerrow CJ; MacKie RM J Cutan Pathol; 1981 Dec; 8(6):404-10. PubMed ID: 6278001 [TBL] [Abstract][Full Text] [Related]
24. A comparison of the -melanocyte-stimulating hormone and corticotropin response to hypoglycemia. Donald RA; Toth A J Clin Endocrinol Metab; 1973 May; 36(5):925-30. PubMed ID: 4349048 [No Abstract] [Full Text] [Related]
25. A radioimmunoassay for beta-melanocyte-stimulating hormone in human plasma. Thody AJ; Plummer NA J Endocrinol; 1973 Aug; 58(2):263-73. PubMed ID: 4353640 [No Abstract] [Full Text] [Related]
26. Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome. Wortsman J; Wehrenberg WB; Gavin JR; Allen JP Obstet Gynecol; 1984 May; 63(5):630-4. PubMed ID: 6326013 [TBL] [Abstract][Full Text] [Related]
27. Seasonal rhythm of the plasma level of alpha-melanocyte stimulating hormone. Altmeyer P; Stöhr L; Holzmann H J Invest Dermatol; 1986 Apr; 86(4):454-6. PubMed ID: 3018089 [TBL] [Abstract][Full Text] [Related]
28. Plasma corticotrophin levels in addison-schilder's disease. Rees LH; Grant DB; Wilson J Br Med J; 1975 Jul; 3(5977):201-2. PubMed ID: 167903 [TBL] [Abstract][Full Text] [Related]
29. Leukemia, drugs and ACTH. Shevitz HA N Engl J Med; 1970 Mar; 282(12):692. PubMed ID: 4313786 [No Abstract] [Full Text] [Related]
30. White Addison's disease: what is the possible cause? Kendereski A; Micić D; Sumarac M; Zorić S; Macut D; Colić M; Skaro-Milić A; Bogdanović Z J Endocrinol Invest; 1999 May; 22(5):395-400. PubMed ID: 10401715 [TBL] [Abstract][Full Text] [Related]
31. [Nail pigmentation during therapy with cyclophosphamide and doxorubicin]. Manigand G; Faux N; Dumas D; Taillandier J; Fixy P; Richerd F Sem Hop; 1983 Jun; 59(24):1840-1. PubMed ID: 6136095 [TBL] [Abstract][Full Text] [Related]
32. Additional evidence for dissociation of melanocyte-stimulating hormone and corticotrophin release. Dunn JD; Kastin AJ; Carrillo AJ; Schally AV J Endocrinol; 1972 Nov; 55(2):463-4. PubMed ID: 4344237 [No Abstract] [Full Text] [Related]
33. MELANOCYTE-STIMULATING HORMONE AND ADRENOCORTICOTROPHIC HORMONE. THEIR RELATION TO PIGMENTATION. LERNER AB; MCGUIRE JS N Engl J Med; 1964 Mar; 270():539-46. PubMed ID: 14091524 [No Abstract] [Full Text] [Related]
35. Factors affecting the release of melanocyte-stimulating hormone in mammals. Howe A Proc R Soc Med; 1969 Sep; 62(9):892-4. PubMed ID: 4309931 [No Abstract] [Full Text] [Related]
36. Synthetic MIF has no effect on beta-MSH and ACTH hypersecretion in Nelson's syndrome. Donnadieu M; Laurent MF; Luton JP; Bricaire H; Girard F; Binoux M J Clin Endocrinol Metab; 1976 Jun; 42(6):1145-8. PubMed ID: 6486 [TBL] [Abstract][Full Text] [Related]
37. Circadian variation in plasma melanocyte stimulating hormone activity in the rat. Dunn JD; Kastin AJ; Carrillo AJ Int J Chronobiol; 1977; 4(3):163-9. PubMed ID: 194850 [TBL] [Abstract][Full Text] [Related]